Skip to main content

HOSPITAL

07/06/2022

Two Vall d’Hebron research papers win at the "Archivos de Bronconeumología" 2022 awards

2022_Premios_Archivo_Bronconeumología
Premis_Archivos_de_Bronconeumología_2022

07/06/2022

The study for the ciliary dyskinesia diagnosis led by the VHIR’s Growth and Development Group has been proclaimed the best basic-research article, while EPISCAN II, in which Dr. Miravitlles has participated, has won the award for the most cited original article in 2021.

The award distinguishes the best articles published in the official journal of this scientific society.

The "Archivos de Bronconeumología 2022" awards have distinguished two investigations by Vall d’Hebron Research Institute’s (VHIR) researchers. The awards have been given by the Spanish Pneumology and Thoracic Surgery Society (SEPAR) national congress held this June. The award distinguishes the best articles published in the official journal of this scientific society.

This year, the award for the best basic-research article has been for the study "Application of a genetic panel for the genetic diagnosis of primary ciliary dyskinesia” carried out and coordinated by the VHIR’ Growth and Development Group, led by Dr. Antonio Moreno, head of the Allergies, Pediatric Pneumology and Cystic Fibrosis Unit at the Vall d’Hebron University Hospital. This multicentric study included patients from Spain who were suspected of suffering from primary ciliary dyskinesia (PCD).

PCD is a rare disease characterized by an alteration of the ciliary structure that prevents the proper function of respiratory secretions. There is not currently a definitive diagnostic tool, instead, a combination of expensive and difficult tests is done. The study has created a high-performance genetic panel, as it has diagnosed 81% of the patients studied, without giving any false positives.

Besides, the study "Prevalence and determinants of COPD in Spain: EPISCAN II" has won the award for the original article most cited in 2021. EPISCAN II is a population-based epidemiological study driven by the pharmaceutical company GSK, whose aim is to investigate the prevalence and causes of Chronic obstructive pulmonary disease (COPD) in Spain. There were 12 hospitals in the study with Vall d'Hebron as the reference hospital of Catalonia. Dr. Miravitlles is part of the scientific committee and is one of the main authors of this study. Other members of the VHIR’s Pneumology Research Group, led by Dr. Ferrer, head of the Vall d’Hebron Pneumology Service and co-director of the aforementioned research group, have also participated in the study.

In total there were 9,433 participants, 53% women and an average age of 60, of whom 11.8% had COPD. The study showed that COPD is one of the most prevalent diseases in the general population and at the same time one of the most underdiagnosed, (three out of four affected had no medical diagnosis).

The "Archivos de Bronconeumología" awards have been held since 2016 within the framework of the national congress of the SEPAR. The SEPAR brings together over 5,200 pneumologists, thoracic surgeons and other respiratory health professionals in Spain.

Related news

The paper has shown that those patients who are not able to normalize their microbiome after surgery have a worse prognosis.

Es va reconèixer la tasca de més de 70 professionals dedicades a aquesta malaltia pulmonar, tant assistencial com de recerca.

Entre els projectes més rellevants en Covid-19 destaca la participació del VHIR en assaigs clínics per provar l’eficàcia i seguretat de vacunes com ara Janssen, Pfizer-BioNTech en el col·lectiu d’embarassades, i Hipra.

Related professionals

Cristina Berastegui Garcia

Cristina Berastegui Garcia

Pneumology
Read more
Victor Monforte Torres

Victor Monforte Torres

Pneumology
Read more
Silvia Sánchez Díez

Silvia Sánchez Díez

Predoctoral researcher
Pneumology
Read more
Ariadna Campos Martorell

Ariadna Campos Martorell

Growth and Development
Read more

Subscriu-te als nostres butlletíns i forma part de la vida del Campus

El Vall d’Hebron Barcelona Hospital Campus és un parc sanitari de referència mundial on assistència, recerca, docència i innovació es donen la mà.